OPEN END TURBO SHORT - RESMED | Market Closed - Börse Stuttgart 01:27:37 15/06/2024 am IST | ||
| 1.33 EUR | +9.02% |
|
| 1 month | +49.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 1.33 | +9.02% |
| 13/24/13 | 1.22 | -8.27% |
| 12/24/12 | 1.33 | -6.99% |
| 11/24/11 | 1.43 | +5.15% |
| 10/24/10 | 1.36 | +2.26% |
Delayed Quote Börse Stuttgart
Last update June 15, 2024 at 01:27 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | MG3BR6 |
| ISIN | DE000MG3BR69 |
| Date issued | 30/04/2024 |
| Strike | 224.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.65 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.84 € |
|---|---|
| Lowest since issue | 0.47 € |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
211.7
USD
Average target price
218.7
USD
Spread / Average Target
+3.30%
- Stock Market
- Certificates
- Certificat
